Patents by Inventor Johan Garssen

Johan Garssen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230000975
    Abstract: The present invention relates to a nutritional composition comprising non-denatured lactoferrin for use in preventing or treating allergy, allergic rhinitis, asthma, urticaria, atopic eczema, allergic conjunctivitis, atopic dermatitis or atopic diseases in an infant or a toddler.
    Type: Application
    Filed: December 11, 2020
    Publication date: January 5, 2023
    Applicant: N.V. Nutricia
    Inventors: Belinda Potappel - van 't Land, Betty Lobato-Van Esch, Suzanne Abbring, Johan Garssen
  • Patent number: 11389492
    Abstract: The invention pertains to the use of a probiotic and a beta-lactoglobulin-derived peptide in the manufacture of a product for use in inducing oral tolerance, and/or treatment, prevention or reducing the risk of allergy in a subject, in particular cow's milk protein allergy.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: July 19, 2022
    Assignee: N.V. NUTRICIA
    Inventors: Leon Matthieu Johannes Knippels, Johan Garssen
  • Publication number: 20220218728
    Abstract: The invention relates to the use of beta1,3?-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 14, 2022
    Applicant: N.V. Nutricia
    Inventors: Saskia Braber, Belinda Potappel - van 't Land, Selma Paulien Wiertsema, Johan Garssen, Bernd Stahl, Marko Mank
  • Publication number: 20220218804
    Abstract: The present invention relates to a combination of Vitamin A and non-digestible oligosaccharides for use in treating and/or preventing allergy.
    Type: Application
    Filed: May 18, 2020
    Publication date: July 14, 2022
    Applicant: N.V. Nutricia
    Inventors: Linette Eustachia Maria Willemsen, Johan Garssen, Leon Matthieu Johannes Knippels
  • Publication number: 20220152066
    Abstract: The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.
    Type: Application
    Filed: February 1, 2022
    Publication date: May 19, 2022
    Inventors: Jeroen VAN BERGENHENEGOUWEN, Johan GARSSEN, Claudia TRAIDL-HOFFMANN, Caroline SCHLUMPRECHT
  • Publication number: 20220023418
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: October 4, 2021
    Publication date: January 27, 2022
    Applicant: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20210346434
    Abstract: Disclosed is a method for treating and/or preventing rotavirus infection in an infant or young child, and its related symptoms comprising administering a nutritional composition that is at least partly fermented by lactic acid producing bacteria and comprises non-digestible oligosaccharides.
    Type: Application
    Filed: January 16, 2020
    Publication date: November 11, 2021
    Applicant: N.V. Nutricia
    Inventors: Catharina Theresia Knipping, Francisco José Pérez Cano, Johan Garssen
  • Patent number: 11135290
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: October 5, 2021
    Assignee: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Patent number: 11090321
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: August 17, 2021
    Assignee: N.V. NUTRICIA
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20210227868
    Abstract: A formula comprising a whey protein hydrolysate comprising specific beta-lactoglobulin derived peptides and probiotics for inducing oral immune tolerance against milk protein, preventing or treating of oral immune intolerance against milk protein, and/or reducing the risk of developing oral immune intolerance against milk protein.
    Type: Application
    Filed: April 18, 2019
    Publication date: July 29, 2021
    Applicant: N.V. Nutricia
    Inventors: Joost Willem Gouw, Laura Antoinette Petronella Maria Meulenbroek, Juandy Jo, Leon Matthieu Johannes Knippels, Johan Garssen
  • Publication number: 20210227869
    Abstract: A formula comprising a whey protein hydrolysate comprising specific beta-lactoglobulin derived peptides and probiotics for inducing oral immune tolerance against milk protein, preventing or treating of oral immune intolerance against milk protein, and/or reducing the risk of developing oral immune intolerance against milk protein.
    Type: Application
    Filed: April 18, 2019
    Publication date: July 29, 2021
    Applicant: N.V. Nutricia
    Inventors: Joost Willem Gouw, Laura Antoinette Petronella Maria Meulenbroek, Juandy Jo, Leon Matthieu Johannes Knippels, Johan Garssen
  • Publication number: 20200222435
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Application
    Filed: September 20, 2019
    Publication date: July 16, 2020
    Applicant: N.V. Nutricia
    Inventors: Bernd STAHL, Alma Jildou NAUTA, Johan GARSSEN, Eric SAMAIN, Sophie DROUILLARD
  • Publication number: 20200155672
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 21, 2020
    Applicant: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Patent number: 10588965
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: March 17, 2020
    Assignee: N.V. Nutricia
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20190388445
    Abstract: The present invention relates to the use of non-digestible oligosaccharides for the direct attenuation of nasal epithelial inflammation, in particular for non-allergic rhinitis, in particular for use in infants.
    Type: Application
    Filed: September 6, 2019
    Publication date: December 26, 2019
    Inventors: Jeroen VAN BERGENHENEGOUWEN, Johan GARSSEN, Claudia TRAIDL-HOFFMANN, Caroline SCHLUMPRECHT
  • Patent number: 10420784
    Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: September 24, 2019
    Assignee: N.V. NUTRICIA
    Inventors: Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
  • Publication number: 20190076490
    Abstract: The invention relates to nutritional compositions with Bifidobacterium breve and non-digestible oligosaccharides for use infants or toddlers for use in improving cognitive or behavioral performance or neuroinflammation.
    Type: Application
    Filed: May 2, 2018
    Publication date: March 14, 2019
    Applicant: N.V. Nutricia
    Inventors: Johan GARSSEN, Ruurd VAN ELBURG, Nana BARTKE, Aletta Desiree KRANEVELD
  • Patent number: 10124016
    Abstract: Disclosed is a nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by S. thermophilus. Said combination synergistically improves the immune system by stimulating the Th1 response, and/or decreasing the Th2 response, improving the vaccination response, improving the resistance against infections and/or decreasing allergy.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: November 13, 2018
    Assignee: N.V. NUTRICIA
    Inventors: Belinda Potappel-Van 'T Land, Leon Matthieu Johannes Knippels, Alma Jildou Nauta, Johan Garssen
  • Publication number: 20180264104
    Abstract: The invention concerns nutritional compositions with fucosyllactose for use in stimulation of NK cells. The composition is suitable for infants.
    Type: Application
    Filed: January 10, 2018
    Publication date: September 20, 2018
    Applicant: N.V. Nutricia
    Inventors: Bernd STAHL, Alma Jildou NAUTA, Johan GARSSEN, Eric SAMAIN, Sophie DROUILLARD
  • Patent number: 10071125
    Abstract: A composition comprising Bifidobacterium breve, a non-digestible saccharide A and a non-digestible saccharide B, optionally combined with Lactobacillus paracasei and the use of said composition for the treatment and/or prevention of gastro-intestinal disorder, immune disorder and/or endocrine disorder.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: September 11, 2018
    Assignee: N.V. Nutricia
    Inventors: Jan Knol, Monique Haarman, Johan Garssen, Adrianus Johannes Maria Vriesema, Martine Sandra Alles